Logo

AxoGen, Inc.

AXGN

AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucos… read more

Healthcare

Medical Devices

36 years

USD

Exclusive to Premium users

Price

per share adjusted in USD

$15.87

Price

+1.80%

$0.28

Market Cap

$730.220m

Small

Price/Earnings

-

Premium

3y Avg

Premium

5y Avg

Financials Overview

Key metrics over the past few years

-

EBITDA Margin

-

Net Profit Margin

-

Free Cash Flow Margin
Revenue

$203.271m

-

1y CAGR

-

3y CAGR

-

5y CAGR
Earnings

-$4.663m

-

1y CAGR

-

3y CAGR

-

5y CAGR
EPS

-$0.11

-

1y CAGR

-

3y CAGR

-

5y CAGR
Book Value

$112.276m

$205.453m

Assets

$93.177m

Liabilities

$68.188m

Debt
Debt to Assets

33.2%

6.3x

Debt to EBITDA
Free Cash Flow

$5.538m

-

1y CAGR

-

3y CAGR

-

5y CAGR

Financial Reports

Earnings and other important metrics. Amounts in USD.
No items found.
Press Releases
Statements and updates from the company
↑ TopSummaryPriceFinancialsPress Releases